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Abstract
Tissue engineering has emerged as an interdisciplinary field to overcome current
challenges for tissue repair or replacement in the human body. In essence, it proposes new
medical therapies customized to match the biology of specific patients. The potential benefits
offered by tissue engineering have driven scientific inquiry to make it a clinical reality.
One of the current challenges in tissue engineering is to provide oxygen supply to thick
tissues as oxygen diffusion is limited to 100 - 200 µm layer of viable tissue. Engineered vascular
conduits are applied in vitro, providing pre-vascularization to tissues; however, host anastomosis
is still a problem. Biomaterials are suggested as another strategy; the aim is to construct scaffolds
able to provide oxygen to cells in a controlled manner. Tissues require a controlled progressive
oxygen supply, otherwise hypoxia or hyperoxia could induce cell necrosis. Inkjet printing
method was developed to dispense living organisms, or biomaterials using a designed pattern.
The hypothesis tested in this study is that scaffolds can be developed to provide a controlled
oxygen supply thereby enhancing cell viability in hypoxic environments.
Calcium peroxide (CaO2) was selected as oxygen generating material. It was
encapsulated in alginate hydrogels to provide a continuous oxygen supply. Inkjet printed
microparticles of CaO2 were evaluated under hypoxic environment (0.01 mol/m3 O2) in direct
contact with culture medium. Samples with a ratio of 2 mg/mL (CaO2/medium) exhaust the
oxygen supply after 30 hours. Oxygen generating scaffolds fabricated with a ratio of 160 mg of
alginate per 10 mg of CaO2 provided a stable oxygen supply in the range of 0.066 – 0.052
mol/m3 under hypoxic environment. Fibroblast L-cells were cultured for 120 hours on these
scaffolds under hypoxia (0.01 mol/m3, 5% CO2, 37 ºC) and their viability was evaluated via
MTS metabolic assay. Statistical differences between oxygenized scaffolds and negative control
scaffolds were observed. Live/Dead assays corroborated these results.
The current study shows a scaffold composed of alginate-hydrogel, and CaO2
microparticles dispensed by the inkjet printing technology, able to supply oxygen in contact with
vi

culture medium. The oxygen generating scaffold was capable of maintaining cell mitochondrial
activity under hypoxic conditions. The inkjet printing method may play an important role to
construct complex scaffolds for tissue engineering applications, where the diffusion of oxygen is
a constraint for large engineered-tissue implants.
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Chapter 1
Literature Review
1.1

FUNDAMENTALS OF TISSUE ENGINEERING
Tissue engineering (TE) is an interdisciplinary discipline which applies the principles of

life science and engineering to overcome current problems of tissue loss or failure, developing
functional engineered tissues for clinical applications [1].
Three principal strategies are used to create tissues [2]: (i) the cells substitute strategy,
which helps targeted cells to perform a required function accomplished by selective cell isolation
and infusion [3, 4]. However, this strategy has the limitation of immunological rejection [5]. (ii)
The tissue-induce substance strategy, which creates new tissue by selection and administration of
growth factors [6, 7] coupled with a targeted delivery [8]. (iii) The biomaterial scaffold strategy,
in which cells and biomaterials are implanted into the host allowing permeation of oxygen,
nutrients, and carbon dioxide (CO2) [9, 10]. This strategy may also include extracorporeal
devices [11]. In a common approach for using biomaterials scaffolds, cells are seeded onto
scaffolds under appropriate conditions and subsequently implanted into the body. The
biomaterials selection for scaffolds depends of the requirements of the tissue to be repaired or
replaced, such as mechanical and chemical properties; these biomaterials can be natural
(alginates) and/or synthetic (polymers) [12]. Immunosuppressive drugs [13] or autologous cells
may be used within scaffolds to prevent immunological rejection [14]. In all the cases, the
strategies are designed to repair or regenerate a tissue structure, and restore some function.
Figure 1.1 shows several strategies of tissue engineering.
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Figure 1.1. Tissue engineering strategies [15]
At the present, TE has provided promising approaches, which includes: (i) the creation of
functional crafts for repairing or replacing damaged tissues [16, 17], (ii) development of complex
biomaterial 3D-scaffolds for construction of artificial organs [18, 19], and (iii) the creation of
engineered tissues models for drug screening [20].
Although, there are important advances in the field, enormous challenges remain; they
include: to ensure adequate oxygen supply to thick engineered tissues; to enhance scaffold
performance; to develop highly biocompatible materials; and recapitulate the appropriate tissue
architecture [21].
1.2

TISSUE ENGINEERING SCAFFOLDS
Different strategies have been developed for constructing engineered tissues using

biomaterials-scaffolds. They serve as a synthetic extracellular matrix that provide support for
growing cells and mimic the desired tissue architecture [22]. Some scaffolds parameters are
porosity, elasticity, stiffness, substance, and specific topography. The scaffolds need to be
degradable, because the cells create their own extracellular matrix, and the new tissue is
integrated progressively with the surrounding host tissue [18, 23, 24]. Poly (lactide-co glycolide)
2

(PLG) is a hydrolytically degradable scaffold material; one of the few approved by the FDA for
clinical applications [25-27]. PLG is a hydrophobic material, and a solvent such as chloroform is
needed during the forming process, requiring extensive cleaning and sterilization before use for
cell attachment and growth [28]. Another class of scaffolds is made from hydrogels, hydrophilic
water swollen materials that are of natural or synthetic origin. Most hydrogel scaffolds are
biodegradable and have similar initial mechanical properties as the tissues in which they are
implanted [29].
The mass transport through the scaffold is critical in tissues, because the constant need of gases,
proteins, nutrients and waste products. The principal mass transport property of interest is the
oxygen diffusion throughout the scaffold to avoid insufficient oxygen levels within the
engineered tissue. Investigations were made using oxygen generating systems, [30, 31] however,
some limitations are still remaining, including the control of ideal oxygen concentrations for
cells, and the control of the 3D oxygenized-scaffold architecture.
1.3

HYDROGELS AS SCAFFOLDS FOR TISSUE ENGINEERING
Hydrogels may be used to create engineered scaffolds using natural or synthetic

biomaterials [32-35]. The advantage of using synthetic hydrogels is that material properties can
be controlled. Examples of synthetic materials for hydrogel formation are: poly vinyl alcohol
(PVA), poly ethylene oxide (PEO) and poly acrylic acids (PAA). Natural hydrogels are used for
scaffolds construction, because their similarity to tissues. Examples of natural hydrogels include:
collagen, hyaluronic acid, chitosan, and alginate. This literature review is focused on natural
hydrogels because they have more prevalence in tissue engineering applications.
1.3.1

Naturally Hydrogel Materials
Hydrogels formed from natural biomaterials have similar properties to the native

extracellular matrix (ECM); hence, they are used for different tissue engineering applications
such as bone scaffolds and skin repair. Most natural derived hydrogels are linear polysaccharides
[37]. As an example, hyaluronic acid (HA) present in animal tissues is widely used as TE
3

scaffold. Collagen is another natural material used as hydrogel scaffold, and is present in the
25% of mammalian tissue [36]. HA and collagen are two examples of hydrogel scaffolds utilized
for TE applications with successful in vivo results [38, 39].
1.3.1.1 Collagen
Collagen has appropriate properties for tissue engineering applications. Collagen is a
protein, and is present in mammalian tissues as the main structure of ECM. Collagen exists in
different types; however, all collagens have the same structure of three polypeptide chains which
form a three-stranded configuration. The strands of the collagen have the property to form fibers
by self-aggregation [36]. Moreover, mechanical properties of collagen can be improved with
chemical cross-linkers such as formaldehyde or carbodiimide [40, 41], using physical treatments
including heat, UV light, freeze-drying [40, 42], and combining it with others biomaterials
including chitosan, PLG, poly lactic acid (PLA) and HA [40, 41, 43, 44]. The degradation of
collagen scaffolds can be locally controlled by cells seeded, because it is degraded by
collagenases [36].
1.3.1.2 Hyaluronic Acid (HA)
HA is the only type of glycosaminolglycan (GAG) that is non-sulfated, and is found in
mammalian fluid and tissue. HA is elemental for skin in tissue repairing, because it promotes cell
proliferation and migration. HA can be formed to hydrogel by different methods, including
covalent crosslinking [45, 46], esterification [47], and annealing [48]. Hyaluronidase catalyzes
the hydrolysis in HA, inducing a natural degradation in the human body.
1.3.1.3 Chitosan
Chitosan is used in different biomedical applications, because its biocompatibility, and
can be naturally degraded in vivo by the enzyme lysozyme. Chitosan is a linear polysaccharide
that can be obtained by reacting shrimp shells with the alkali sodium hydroxide [49]. Chitosan
needs to be dissolved first in dilute acids to form the gelation, which can be induced by
increasing pH or extruding the solution [50, 51]. Chitosan derivatives can be formed into gels by
4

several methods, including glutaraldehyde crosslinking [52, 53], ultra violet radiation [54], and
freeze-drying [49, 51].
1.3.1.4 Alginate
Alginate hydrogels are used as scaffolds for tissue engineering applications in particular
for bone. The advantage of this material is that gelation can be controlled, and it is highly
biocompatible. This material is an anionic polysaccharide copolymer, which is obtained from
brown seaweed and bacteria [56]. The monomer M-residues and G-residues of alginate appears
consecutive or as interchanging blocks [56, 57]. The particular sequential arrangement of the
monomers is affected by the species of the seaweed, its origin and age [56]. Gelation occurs
when alginate interact with divalent cations including Ca2+ and Ba2+. The hydrogel mechanical
properties can be controlled by selecting species with varying the monomers (G and M) ratios
and molecular weight [58]. Since alginate hydrogels are only physically crosslinked, they are
subject to uncrosslink by ion exchange, resulting in loss of strength over time [59]. Alginate may
be synthesized to be hydrolytically degradable by partial oxidation, and a derivative such as
polyguluronate [60] creating oxidized alginate [61] and PLG [62].
1.4

STRATEGIES TO PROMOTE VASCULARIZATION WITHIN ENGINEERED TISSUES
Supply of adequate amount of oxygen to the engineered scaffolds is crucial to maintain

the cells viability within the scaffold. The oxygen diffusion into tissues is maximum 200 µm [63,
64], hence hypoxic conditions are established within the tissue microenvironment at distances
above 200 µm from blood vessels. To overcome this limitation, different strategies are used to
incorporate oxygen and improve viability of implanted cells; these include: (i) angiogenic growth
factors [65], (ii) synthetic oxygen carriers [66], and (iii) oxygen generating materials [30, 31].
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1.4.1

Angiogenic Growth Factors
Angiogenesis is defined as a physiological process where new vessel formation occurs

from a preexisting vascular network [67]. The sequence of angiogenesis take place in the
following stages: (1) capillary wall degradation, (ii) cell migration, (iii) branch point formation
in vessel wall, (iv) new formation arrangement to form a central lumen, and (v) new branched
network formation by anastomosis [68]. Direct or indirect the vascularization in vivo is
orchestrated by angiogenic growth factors which are present in the natural wound healing, tissue
regeneration, and organ growth. There are four principal groups of angiogenic growth factors,
these include, epidermal growth factors, fibroblast growth factors, platelet-derived growth
factors, and transforming growth factors [69].
1.4.2

Vascular Endothelial Growth Factor
Vascular endothelial growth factor (VEGF) induces angiogenesis in vivo by activating

endothelial cells. Cardiac myocytes and retinal cells discharge four isoforms of VEGF having
121, 165 and 206 amino acids [70, 71]. The level of VEGF is increased when tissue is exposed to
hypoxic environment in vivo as demonstrated by cardio myocytes that showed high VGEF
expression under ischemic conditions [72].
1.4.3

Fibroblast Growth Factors
The fibroblast growth factor family is divided in four groups that promote vascularization

to fibroblast cells, including FGF-1, FGF-2, FGF-4 and FGF-5 [73]. Acidic FGF and basic FGF
are the most characterized factors respective with angiogenic potential that are found in ECM
[74]. The four groups of the FGF family induce mitogen stimulus in different paths, stimulating
endothelial cells to express urokinase-type plasminogen activator (uPA), and collagenase [75].
Endothelial cell proliferation and migration is promoted by fibroblast growth factor [76, 77].
Acidic FGF and basic FGF promote cell division for smooth muscles cells [78]. Acidic FGF
produces mitogenic stimulus to cardiomyocytes and induces capillary formation [79].
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1.4.4

Platelet-Derived Growth Factor
Platelet-derived growth factor (PDGF) is found in platelets, monocytes, macrophages

smooth muscle cells, and endothelial cells. PDFG produces mitogenic stimulus to fibroblast, and
smooth muscle cells that subsequently induces VEGF expression [73, 77]. Transforming growth
factor beta-1 induces the expression of PDGF [80]. PDGF released by endothelial cells is related
to the pericytes wrapping, and endothelial cell differentiation [77].
1.4.5

Transforming Growth Factor-Beta
Transforming growth factor-β (TGF-β) is a homodimer found as one of five isoforms (β1,

β2, β3, β4 and β5). TGF- β1 is released from cells that are triggered by plasmin. TGF- β1
decreases endothelial cells proliferation in vitro [77], but promotes new vessels formation in vivo
[82]. TGF- β1 induces angiogenesis by different mechanisms promoting several angiogenic
growth factors, such as PDGF expression by endothelial cells that subsequent stimulates smooth
muscle cells to release VEGF and basic FGF [78]. TGF- β also stimulates the angiogenic
reaction of cells to PDGF [83]. TFG- β1 is found in several cells, such as platelets and
macrophages [84].
1.4.6 Artificial Oxygen Carries
Artificial oxygen carriers are proposed to improve oxygen delivery to tissues, and also
used as blood substitutes. These carriers are designed to dissolve oxygen and CO2 in large
quantities, serving as a vehicle for transporting oxygen and removing waste. Modified
hemoglobin and perfluorocarbon emulsions are the main artificial oxygen carries [85, 86].
Modified hemoglobin has a similar oxygen solubility curve as blood, and perfluorocarbon
emulsions have a linear oxygen concentration with partial pressure [87]. Modified hemoglobin as
oxygen carrier is currently being investigated to improve the oxygen transport to hepatocytes in
culture [88, 89].
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Perfluorocarbons are applied in cardiovascular surgeries as blood substitutes. The FDA
approved several perfluorocarbons systems for clinical applications [90]. Perfluorocarbons made
into gels can be applied to wounds acting as protecting covering while delivering oxygen [92].
Moreover, alginate scaffolds containing perfluorocarbons are investigated for creating a suitable
microenvironment for cells in tissue engineering applications [93].
1.4.7 Oxygen Generating Materials
Solid peroxides generate oxygen when reacts with water, such as magnesium peroxide
(MgO2) and calcium peroxide (CaO2). Oxygen is generated in two steps; first, solid peroxides
react with water resulting hydrogen peroxide as product (Eq 1.1 and Eq. 1.2), subsequently
oxygen is generated by the decomposition of hydrogen peroxide (H2O2) (Eq. 1.3) [94, 95].
Reaction equation is indicated below.

CaO2+2H2O

Ca(OH)2+H2O2

Eq. 1.1

MgO2+2H2O

Mg(OH)2+H2O2

Eq. 1.2

2H2O2

O2 2H2O

Eq. 1.3

CaO2 is the most efficient of the solid peroxides as oxygen generating systems in
comparison with MgO2, which has the slowest reaction kinetics, because its low solubility in
water [96]. CaO2 is found in commercial formulations at 80% purity while MgO2 can be found at
25% purity by weight [97, 98]. In addition, CaO2 has been used as oxygen-generating compound,
because the affordability and availability. Another advantage of solid peroxides for tissue
engineering applications is their biocompatibility.
Catalase is an enzyme present in mammalian blood and liver that acts as a catalyst to
accelerate the decomposition of H2O2 into oxygen and water [99, 100, 101]. The mechanism of
catalase is not known precisely, but it is estimated that decomposition reaction of H2O2 is given
by the following equations:
8

H2O2+2Fe3+

O2+2Fe2++2H+

H2O2+2Fe2++2H+

Eq.1.4

2H2O+2Fe2+

Eq.1.5

The presence of H2O2 in cells culturing is known to be toxic for cells, hence many
investigators have added catalase to the culture medium.
1.4.8

Inkjet Printing for Tissue Engineering Applications
Inkjet printing technology consists of depositing drops of ink by a non-contact

reproductive technique that is controlled by a computer to reproduce a designed pattern [102].
This technique has been applied with promising results to biomedical engineering applications,
including drug screening, genomics, biosensors, and tissue engineering [19, 103-105]. The
modified printers were successfully used for performing different approaches, such as printing
self-assembled monolayers, proteins and other molecules [107]. In addition, this technology has
been used to place cells and biomaterials into patterns and thus construct TE scaffolds. [108-110]
Figure 1.2 shows a hydrogel scaffold constructed by the inkjet printing technology from
reference [106].

Figure 1.2. Hydrogel Scaffold constructed by inkjet printing technology [106]
9

1.5

STATEMENT OF THE PROBLEM
Tissue Engineering (TE) has been originated as a solution to overcome the shortage of

transplantable organs. Currently, the transplantation of engineered tissues is done in relatively
thin layers to allow angiogenesis after implantation in order to meet the oxygen and nutrients
demand. The lack of post-implantation vascularization is the principal obstacle to use thick
engineered tissues, such as clinical applications in heart and liver. Although porous scaffolds
loaded with living cells and growth factors are investigated to create engineered thick tissues;
nevertheless, the ability to provide enough oxygen to cells within the scaffold remains the
principal challenge. Immediately after implantation, oxygen is limited to the scaffold surface,
leaving the interior of the scaffold with restricted or no oxygen at all, thereby jeopardizing the
viability and proliferation of the imbedded cells [116]. This has widely been recognized as the
critical limiting factor for developing readily large functional tissues for clinical applications
[117].
To promote the oxygen diffusion in engineered tissues, several strategies are investigated
including the use of growth factors, artificial oxygen carries or oxygen generating materials. The
use of angiogenic growth factors, such as vascular endothelial growth factor [72] is restricted by
the relatively slow angiogenesis rate, thus limiting the size of the implant [118]. Other strategy is
to implant the tissue into similar vascularized tissue for maintaining cell viability and promote
vascularization [14]. Nevertheless, this vascularization method is not possible when the implant
is distant to the target tissue. Perfluorocarbons and crosslinked hemoglobin as synthetic oxygen
carriers [93, 119] are in the early stages of development and some studies demonstrated that they
may improve the cell microenvironment [30]. The purpose of this study is to construct oxygen
generating scaffolds depositing microparticles by the inkjet printing technology [120, 121], and
providing a sustainable microenvironment to cells at hypoxic conditions.
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1.6

HYPOTHESIS:
It is hypothesized that inkjet printing technology can be applied to construct oxygen

generating scaffolds by printing microparticles of calcium peroxide and hydrogel in a designed
pattern. Fabricated scaffolds can provide progressive oxygen supply to cells that are in hypoxic
environment, and improve cell viability and growth.
1.7

OBJECTIVE 1
The first objective is to determine how the amount of calcium peroxide microparticles

printed relates to the oxygen generation per ml of cell culture medium.
1.7.1

Approach of Objective 1
Modifications to an inkjet printer (HP model 697C, Palo Alto, CA) are limited to

removing the rubber cleaners, which is used to clean the cartridges nozzles, and bypassing the
feed page sensor with push button switch. Black inkjet cartridges (HP 29) were emptied of their
content and washed thoroughly, furthermore, were rinsed with a 70% ethanol solution and
distilled water. The cartridges were dried in a sterilized Labculture® Class II - Type A2
Biological Safety Cabinet (ESCO, PA, USA) before being filled with calcium peroxide
solutions.
Calcium peroxide (CaO2) microparticles were suspended in pure ethanol (Aldrich-Sigma,
MO, USA) to form the functional ink. Pure ethanol does not dissolve CaO2 and prevents
premature oxygen release. The microparticles were deposited into a 50 mL conical tube, and
mixed with 10 mL of the ethanol to obtain a 1% (w/v) suspension. This suspension was mixed
with a vortex mixer (Fisher Scientific, PA, USA). The solution was printed onto a glass slide
substrate at different densities, and subsequently placed into a nitrogen purged petri dish
containing cell culturing medium made of Dulbecco’s modified Eagle’s medium (DMEM,
Gibco, USA), 10% fetal bovine serum (FBS, Gibco), 500 U/mL penicillin (Gibco), 500 mg/mL
streptomycin (Gibco), and 100 U/mL of catalase from bovine liver (Sigma, USA). The dish was
placed into a hypoxic chamber (BioSpherix, USA), and oxygen concentrations were measured
11

until they reached background levels of 1%. The oxygen concentration levels were measured in
function of time, and the amount of CaO2 microparticles in the sample provided the information
to design the appropriate release system.
1.8

OBJECTIVE 2
Objective 2 is to determine the ratio of calcium peroxide density and hydrogel content to

obtain optimal oxygen delivery
1.8.1

Approach of Objective 2
A biodegradable hydrogel was prepared by dissolving alginate (Acros Organics, NJ,

USA) in distilled-water at 2% wt. Different volumes of alginate solution were poured onto the
calcium peroxide particles samples. After that, 0.25M of CaCl2 was added (Acros Organics, NJ,
USA) as described here [112] to promote crosslinking and encapsulating the calcium peroxide
particles. The oxygen release as function of alginate gel thickness was obtained.
1.9

OBJECTIVE 3
Objective 3 is to verify that oxygen-generating scaffolds can improve cell viability and

growth under hypoxic conditions.
1.9.1 Approach of Objective 3
Fibroblast cell line L-cell was used as testing model. Other authors demonstrated that L-cells
have optimal proliferation between 5 and 13% of oxygen concentration [113]. Scaffolds were
prepared as in objective 2, and L-cells were seeded with known densities. Three different groups
were prepared: negative control, positive control, and oxygen-generating scaffolds. The negative
control and oxygen generating scaffolds were placed in hypoxic incubation (1% O2, 5% CO2).
The positive control scaffolds were cultured at normoxic incubation (20% O2, 5% CO2). All
scaffolds were washed with PBS for improved cell seeding efficiency [30].
The scaffolds were cultured in DMEM containing 10% FBS, 500 U/mL penicillin, 500
mg/mL streptomycin and 100 U/mL of catalase. The culture medium was changed every day
12

using nitrogen (N2) purged culture medium to prevent external oxygenation of the scaffolds. The
viable cells number in the scaffolds was assessed every day using MTS assay for a total of 10
days.
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Chapter 2
Correlation of Bioprinting of Solid Peroxide Microparticles and Oxygen
Generating
2.1

INTRODUCTION
Oxygen generating materials are suggested for tissue engineering applications to

overcome the current problem of hypoxia in engineered tissues [1]. One such class of materials
that has received some attention lately is the one of solid peroxides. Calcium peroxide (CaO2),
the most commonly used of the solid peroxides, decomposes into hydrogen peroxide upon
exposure to water. The hydrogen peroxide subsequently decomposes into water and oxygen in a
second step. The second step requires a catalyst such as catalase, an enzyme founding in the
blood and liver. Calcium peroxide was used to oxygenate scaffolds in previous studies, but the
oxygen generating particles are not distributed evenly enough to provide a uniform oxygen level
[2].
Inkjet printing technology is a fabrication technique, where a modified off-the-shelf
printer can print living organisms in a designed pattern [3]. The advantages of this technology
are: high through put, drop on demand, variety of materials can be printed, and low cost [4]. This
technology has been applied in biomedical engineering with promising results in drug screening,
genomics, and biosensors. [5-7]. More recently, inkjet printing technology has been used in
tissue engineering applications, where cells and biomaterials were printed to construct scaffolds
and cellular structures [8]. In this study, inkjet printing technology is applied to control the
dispensing of calcium peroxide microparticles.
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2.2

MATERIALS AND METHODS

2.2.1

Printer and Cartridge modifications
The modifications to the HP printer model 697C (Hewlett-Packard, Palo Alto, CA) were

limited to removing the rubber cleaners and their respective springs that are used to clean the
cartridges nozzles. Moreover, the feed page sensor was bypassed and a push-button switch was
added (See figure 3.1). Black ink-jet cartridges (HP 29) were emptied of their content and
thoroughly washed with a 70% ethanol solution and distilled water. Then the cartridges were
dried in a biological safety cabinet before to being used.

Figure 2.1. Photograph of the modified HP 297C Printer.
2.2.2

Ink preparation
Calcium peroxide (CaO2) powder (Sigma-Aldrich, MO, USA) was deposited into a 50

mL tube and mixed with 10 mL of 200-proof ethanol (Sigma-Aldrich, MO, USA), obtaining a
suspension of 1% wt. Then the suspension was mixed with a vortex mixer (Fisher Scientific, PA,
USA), filtered with a 40 µm mesh (Fisher Scientific, PA, USA), and dispensed in the printing
cartridge.
2.2.3

Volume printed prediction
In determining the amount of volume being dispensed by the inkjet printer, a given

volume of a fully saturated sodium chloride solution (30%) (Acros Organics, Geel, Belgium)
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was printed, dried, and weighed. The following patterns were thus printed. As control, a volume
of 100 µL was dispensed onto substrates under a conventional micropipette.
A)

Figure 2.2.

2.2.4

C)

B)

Patterns printed for volume determination. . (A) Dot size 0.05”, (B) Dot size 0.10”,
(C) Dot size 0.15”

Printing of designed patterns
The calcium peroxide suspension was printed according to the patterns shown in Figure

2.3, varying the over-printings to deposit a total of 1 mg, 5 mg and 10 mg, onto a 22x22 mm
glass slides. The glass slide was pre-heated to 80 ºC to accelerate the solvent evaporation. The 1
mg group was obtained by printing 64 layers, the 5 mg group had 320 layers, and the 10 mg
group had 640 layers printed, replacing each cartridge with a new one every 32 layers. After the
samples were dried out at room temperature, the weights of the samples were measured.

Figure 2.3. Printing Pattern
2.2.5

Oxygen concentration measurements
Culture medium was Dulbecco’s modified Eagle’s medium, with 10% FBS, 500 U/mL

penicillin, 500 mg/mL streptomycin (Gibco, San Diego, CA), and 100 U/mL of catalase (Sigma24

Aldrich, MO, USA). Oxygen concentration was measured over time at hypoxic environments of
0.01 mol using a specially designed glove box system (BioSpherix, Lacona, NY) (see figure 2.4)
Media was purged for 24 hours with N2 and oxygen concentration was confirmed by an oxygen
sensor. Negative control samples containing normoxic oxygen concentration levels at 0.18 mol
were placed into 50 ml tubes. Continuous oxygen readings were obtained by an oxygen sensor
(OAKTON Instruments, IL, USA). The measurements were recorded over time until the media
reached background levels of oxygen concentration at 0.01 mol.
To measure the oxygen release rate from the printed calcium peroxide microparticles,
three groups were evaluated under hypoxic conditions by placing the samples into 6 well-plates
containing 5 ml of purged culture media. The three concentrations of CaO2 to culture media
were: 0.02 %, 0.1% and 0.5%. The oxygen concentration measurements were taken periodically
with the sensor until it reached hypoxic levels. A pH-meter was used to measure the pH of the
culture media.

Figure 2.4. GloveBox System.
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2.3

RESULTS

2.3.1

Obtaining equation of volume printed
The patterns of printed NaCl are shown in Figure 2.5, and the physical dimensions were

0.05, 0.10, and 0.15 inches in diameter according to the software which ultimately corresponded
to actual printed areas of 1.24, 5.30, and 11.87 mm2, respectively. The dispensed volumes were
4.84, 27.76, and 60.16 nanoliters. Data were plotted adding the natural value of 0,0 (area,
volume) and different trend lines were draw. A positive correlation was found within the two set
of data (correlation = 0.99946), which confirms the direct relation between the area of the dot
and the volume dispensed. A trend line was found to be the best line fit (regression line) (Rsquared = 99.89) that resulted in a linear equation that describes the behavior of the volume with
respect to the printed area. The resulting equation was:

Eq. 2.1

Volume (y) = 5.1307 area(x)-0.4467

This equation was used to predict the amount of calcium peroxide dispensed per the
printing designed pattern.

Figure 2.5. Patterns printed for volume determination. (A) Dot diameter 0.050”. (B) Dot
diameter 0.100”. (C) Dot diameter 0.150”. (D) Control, 100 µL deposited manually
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Sodium chloride solution was found to be an accurate substance to be used as a control
for the volume determination test, as its percentile error of 8.99%.

The results of the three different sets of printed CaO2 particles are shown in table 2.1.
Table 2.1. Mass of printing of pattern layers of CaO2-Ink
Printing Passes

Mass predicted (mg)

Mass (mg); Average n=3

Error (%)

64

1.0

0.9

10%

320

5.0

4.3

14%

640

10.0

11.6

16%

2.3.2

Oxygen concentration of medium in a hypoxic environment over time
Figure 2.6 shows the oxygen concentration in the media as function of time. Oxygen

concentration decreases from normoxic (0.18 mol/m3) to hypoxic (0.01 mol/m3) levels in 60
minutes. Hence, this result suggested that cells incubated under those conditions may experiment
hypoxia after 1 hour, excluding the oxygen cells consumption. The results show exponential
oxygen diffusion to the environment, which is governed by Fick’s law, where postulates that
diffusion goes from region of high concentrations to region of low concentrations with a
magnitude that is proportional to the gradient concentration. The plot was fitted with a
logarithmic equation, y (concentration) = -0.036ln (time) + 0.1499, which seems to underscore
this point.
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Figure 2.6. Oxygen concentration of medium versus time under hypoxic environment
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2.3.3

Correlation of oxygen concentration with calcium peroxide density
Figure 2.7 shows the plotted results of the 0.02 % CaO2 group in culture medium under

hypoxic conditions. The oxygen concentration in the media decreased exponentially. The
maximum oxygen concentration of 0.104 mol/m3 occurred at 9 minutes after exposure to the
culture medium. Oxygen concentration reached background levels after 8.5 hours, which is
850% higher than samples without CaO2.
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Figure 2.7. Oxygen generations from a 0.02% calcium peroxide solution in culture media
(n=3).
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9

Figure 2.8 shows the plotted results of the 0.1 % CaO2 group in culture medium under
hypoxic conditions. The oxygen concentration reached background levels after 25 hours and the
oxygen concentration peak was 0.22 mol/m3 at 7 minutes after exposure to culture medium. The
maximum oxygen concentration was two times greater that the group 0.02%, and the oxygen
exhaustion were prolonged for 16.5 hours. The oxygen concentration stayed above the hypoxia
level of 0.05 mol/m3 for 21 hours.

0.25

O2 Concentration
0.1% CaO2

0.2

mol/m3

0.15

0.1

0.05

0
0

5

10

15

20

25

30

Time ‐ hours

Figure 2.8. Oxygen generations from a 0.1% calcium peroxide solution in culture media (n=3)
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Figure 2.9 shows the plot of the dissolved oxygen concentrations for the 0.2% CaO2
group. The media reached hypoxic levels after 30 hours, and during the initial 15 minutes, the
oxygen level was at hyperoxia levels of 0.62 mol/m3. The pH readings obtained during the study
was between 6.79 and 7.27, which is suitable for cell culturing.
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Figure 2.9. Oxygen generations from 0.2% of calcium peroxide solution in culture media (n=3)
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2.4

DISCUSSION
Inkjet printing technology is a fabrication technique that has been applied for printing a

variety of materials and/or living organisms for different applications [9]. Previous authors
demonstrated that this fabrication technique can be used to construct complex hydrogel scaffolds
[10]. In this study an equation was obtained to predict the mass dispensing by the modified offthe-shelf printer HP697C. The mass predicted for printing 1 mg, 5 mg and 10 mg of CaO2
microparticles had a percentage error of 10%, 14% and 16% respectively. This variation may
refer to the particles sedimentations, which affect the nozzles during printing process. In a
previous study, living organisms were dispensing using inkjet printing technology with a
percentage error of 35% [11]. The capability of mass dispensing in the range of milligrams
represents an important advantage for biofabrication, where constructing scaffolds composed of
different materials with a controlled position is required.
Oxygen concentration of culture medium was evaluated in a hypoxic environment.
Oxygen diffusion from the medium to the hypoxic environment is governed by Fick’s second
law, where oxygen diffusion with time “t” in one dimension from a boundary at “x = 0”, and the
concentration maintained at a value “n0” is described below:
,

Eq.2.2

√

Where “n0” is 0.16 mol/m3, time “t” in seconds, length “x” is 0.005m, D = 3x10-9m2/s
[12] and with an “erfc” value of 0.157. The figure 2.10 shows the equation plotted with respect
time “t”, and the values obtained during the experiment are represented in the same graph. The
exponential decay of the oxygen concentration in the media correlates with the oxygen diffusion
calculation by Fick’s second law equation.
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Figure 2.10 Oxygen concentration of culture medium under hypoxia conditions. Experimental
data vs Fick’s law model data.
Calcium peroxide is used for different applications to release oxygen for sustained time
periods in agriculture and aquaculture [13, 14]. Calcium peroxides have been used to generate
oxygen in tissue engineering scaffolds, and studies suggest that they are suitable for cell
culturing [15]. Calcium peroxide generates oxygen when is in contact with water according to
the following equations [16]:

2
2

Eq. 2.3
2

Eq. 2.4

One concern about using calcium peroxide for tissue engineering applications, is that the
first decomposition steps is the generation of hydrogen peroxide, leading the presence of reactive
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oxygen species. Hence, catalase was incorporated to the cell culture medium to accelerate the
reaction of hydrogen peroxide [17].
Inkjet printing technology was used to print calcium peroxide microparticles (< 40 µm),
forming three groups of 0.02%, 0.1% and 0.2% solutions (n=3). The theoretical O2 generations
from these groups are shown in table 2.2 below.

Table 2.2. Theoretical Oxygen generation of CaO2/Medium proportion: 0.02%, 0.1% and 0.2%.
CaO2 concentration w/V

Theoretical O2 generation

0.02 %

0.77 mol/m3

0.1%

3.85 mol/m3

0.2%

7.70 mol/m3

The oxygen generated by the three calcium peroxide/medium proportions described
above was estimated by numerical integration (trapezoidal rule) as follows:

∑

Eq. 2.5

Where (a – b) is the time spacing, and [f(xk), f(xk+1)] are the measurements obtained by
the oxygen sensor. The data obtained by the sensor is showed in Appendix 1. The table 2.3
shows the percentage yield of the three CaO2 concentrations. The numerical integration was
performed by using 0.25 hours as initial point for the three groups (0.02%, 0.10%, and 0.2%),
because the oxygen level from 0.2%-CaO2/medium proportion was superior to the sensor limits
(0.6 mol/m3) during the first minutes. The percentage yield starting was calculated by dividing
the amount of oxygen calculated under the curve (numerical integration) over the theoretical
oxygen generation. In this conditions the group 0.02% showed a low fractional yield, which can
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be attributed to the space between microparticles, because the low printing density, leading a
quick reaction during the first 15 minutes. The other two groups with a CaO2/Medium proportion
of 0.1% and 0.2% had a similar percentage yield of 52.4% and 47.2% respectively. The
percentage yield of the groups 0.1% and 0.2% may be correlated to the printing layers of the
compound that delayed the contact with water, and the increasing of the alkalinity, because the
high CaO2 density particles increased the pH to 7.27 [18].

Table 2.3. Percentage yield of CaO2/Medium proportion: 0.02%, 0.10% and 0.20%.
CaO2

2

Total O2 generated

100

2

concentration w/V
0.02%

0.273 mol/m3

35.5%

0.1%

2.018 mol/m3

52.4%

0.2%

3.640 mol/m3

47.2%

The results indicate that calcium peroxide microparticles printed in the range of
milligrams may release oxygen for a long time period, which are similar with other studies where
used calcium peroxide for different applications [19]. Calcium peroxide has been used for
incorporating oxygen to scaffolds using highly hydrophobic materials due to the concern of
premature oxygen exhaustion [20]. Further studies are suggested for incorporating calcium
peroxide to hydrophilic materials scaffolds, because their high biocompatibility, such as
collagen, alginate, and chitosan, that have been applied with successful results in tissue
engineering applications [21-23].
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2.5

Conclusions
Inkjet printing technology has been used to dispense calcium peroxide microparticles in a

controlled mass and pattern in a layer-by-layer fashion. Calcium peroxide is a compound that is
capable of generating oxygen for long periods, when is in direct contact with water. Oxygen
generated from this compound reach levels above normoxic conditions, and when the compound
density is increased, the percentage yield is increased, and exhaustion time is prolonged. Using
inkjet printing technology to incorporate oxygen-generating biomaterials to hydrogel scaffolds
may improve cells environment in hypoxic conditions.
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Chapter 3
Oxygen Generating Scaffolds
3.1

INTRODUCTION
One of the current challenges in tissue engineering is the development of methods to

increase oxygen availability for cells within engineered tissues. In the early period of tissue
implantation, an inadequate oxygen delivery occurs due to the angiogenesis delay [1], inducing
necrosis to cells farther than 200 µm from vasculature [2, 3]. Oxygen generating scaffolds may
present a solution to overcome this challenge.
Oxygen concentration gradients are critical for tissue engineering scaffolds, since
hypoxia decreases generation of ATP and vital cellular functions are affected, whereas hyperoxia
can damage cell membrane and DNA. [4]. Incorporation of calcium peroxide to highly
hydrophobic biomaterials such as polydimethylsiloxan (PDMS) and Poly lactic co-glycolic acid
(PLGA) scaffolds were studied [5, 6]. However, investigation in hydrophilic materials has not
been performed yet.
Alginate hydrogel is a hydrophilic biomaterial that is used for tissue engineering
applications, which include cardiac scaffolds and bone scaffolds [7, 8]. In the chapter 3, we
found that 0.1% calcium peroxide solution in media generated oxygen levels from 0.6 mol/m3 to
0.2 mol/m3 during the first 4 hours, and continued generating oxygen for 30 hours.
In this study alginate hydrogel was used to encapsulate the calcium peroxide
microparticles dispensed by the inkjet printing technology in a designed pattern; this technology
has been implemented for different biomedical applications, such as, genomics, drug screening,
biosensors, and tissue engineering [9-12]. Oxygen supply from scaffolds was evaluated in
function of time, using as control, the lowest suitable oxygen concentration for fibroblast cells
(0.05 mol/m3)[13].
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3.2

MATERIALS AND METHODS

3.2.1

Oxygen Generating Scaffolds Construction
Oxygen generating ink was prepared with pure ethanol and calcium peroxide powder

(Sigma-Aldrich, St. Louis, MO) with a concentration of 1% wt. A modified commercial HP697C
(Hewlett-Packard, USA) printer, and a modified HP29 cartridge were used to print the
microparticles of calcium peroxide in a controlled pattern. The ink was filtered (40 µm) to avoid
clogging issues during printing. The microparticles were printed onto a glass slide with a pattern
of 25 dots. 640 printing layers were required to print 10 mg of CaO2. Five printed samples were
dried out overnight at room temperature.
Alginate (Acros Organics, NJ) solution was prepared with a concentration of 2% wt in
sterilized phosphate buffered saline (PBS). The five calcium peroxide samples were placed into a
6-well plate, and the alginate solution was poured into each well plate covering the
microparticles. The resulting five CaO2/alginate concentrations (w/v) were: 0.25%, 0.2%, 0.17%,
0.14% and 0.12%. Hence, the alginates to CaO2 rations included (w/w) 8:1, 10:1, 12:1, 14:1 and
16:1. Calcium chloride (Acros Organics, NJ) (0.25M) was used to promote cross-linking in the
alginate chains. Calcium chloride creates a quick cross-link with alginate, leading to non-uniform
hydrogel geometries. Therefore, 5 ml of CaCl2 solution (0.25M) was added to the samples using
a sprayer nozzle, resulting in a uniform hydrogel. The remaining calcium chloride solution was
removed 5 minutes after the application, and pure ethanol was added to each scaffold before to
be placed under direct UV light for 30 minutes. The ethanol was removed, and the scaffolds were
washed with sterilized PBS. Afterwards, the scaffolds were placed into a chamber at hypoxic
settings (0.01 mol/m3 O2, 5% CO2).
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3.2.2

Oxygen Release Measurement
Culture medium was purged for 24 hours under hypoxic conditions in a special chamber

(BioSpherix, Lacona, NY) at 0.01 mol/m3 O2 and 5% CO2. Subsequently, 5 ml of culture
medium consistent of Dulbecco’s modified Eagle’s medium, 10% FBS, 500 U/mL penicillin,
500 mg/mL streptomycin (Gibco, San Diego, CA), and 100 U/mL of catalase (Sigma-Aldrich,
MO, USA) was added to each scaffold; the oxygen levels were measured using an oxygen sensor
(OAKTON Instruments, IL, USA) until oxygen background levels were reached.

3.3

RESULTS
Five samples with 10 mg of calcium peroxide microparticles were printed in 25 dots

pattern. Each sample was encapsulated with a different concentration of alginate to evaluate the
oxygen generating in function of time. Figure 3.1 shows the scaffolds used for this study.

Figure 3.1. Alginate-Hydrogel Scaffolds.
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Figure 3.2 shows the scaffold constructed with 8:1 of alginate per CaO2. The oxygen
concentration was maintained in suitable levels for 45 hours. After 45 hours the oxygen
concentration in the culture media drops below the inferior limit of suitable oxygen levels for
cell culturing. At 72 hours the oxygen concentration reached background levels.
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Figure 3.2. Oxygen generating measurements from scaffold ratio: 8:1 alginate CaO2 (n=1).
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Figure 3.3 shows the scaffold with 10:1 alginate-CaO2 ratios. The maximum oxygen
concentration reading was at 22 hours with an oxygen content of 0.13 mol/m3. After 45 hours the
oxygen level was 0.016 mol/m3 above the control lower limit for cell survival. The culture media
reached oxygen background levels at 72 hours.
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Figure 3.3. Oxygen generating measurements from scaffold ratio: 10:1 alginate CaO2 (n=1).

43

80

Figure 3.4 shows the scaffold with 12:1 alginate-CaO2 ratios. The maximum oxygen
concentration reading was at 22 hours with an oxygen content of 0.098 mol/m3. Oxygen drops
below control levels after 55 hours. At 96 hours the culture medium reaches background oxygen
levels.
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Figure 3.4. Oxygen generating measurements from scaffold ratio: 12:1 alginate CaO2 (n=1)
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Figure 3.5 shows the scaffold with 14:1 alginate-CaO2 ratios. Oxygen drops below the
control limit after 72 hours. The maximum oxygen concentration reading was at 22 hours with a
reading of 0.08 mol/m3. At 120 hours the culture media reached background oxygen
concentration levels.
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Figure 3.5. Oxygen generating measurements from scaffold ratio: 14:1 alginate CaO2 (n=1)
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Figure 3.6 shows the scaffold with 16:1 alginate CaO2 ratios. The scaffold maintained
oxygen concentration above the lower limit of cell survival of 0.05 mol/m3 for 120 hours. The
maximum oxygen concentration reading was 0.066 mol/m3 at 22 hours. After 120 hours of
scaffold expose to culture medium, the oxygen concentration in the media was 0.052 mol/m3.
After 144 hours the scaffold was degraded.
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Figure 3.6. Oxygen generating measurements from scaffold ratio: 16:1 alginate CaO2 (n=1).
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3.4

DISCUSSION
Vascularization is required to maintain cell viability within tissue implants [14].

Biomaterials mixed with oxygen generating compounds have been investigated to prolong cell
survival under hypoxic environment [5, 6]. However, oxygen gradients are present on the
scaffolds, and cell damage may occur [4]. In this study, oxygen generating scaffolds were
fabricated by encapsulating oxygen generating particles that were printed in a designed pattern.
Oxygen supply was evaluated under hypoxia.
Calcium peroxide was selected as oxygen-generating compound [15, 16], which was
encapsulated with alginate hydrogel; oxygen generation was maintained for several days.
Calcium peroxide is used in different industries, such as agriculture to release oxygen for long
period of time [17]. Alginate is commonly used in tissue engineering applications [18], and drug
delivery [19], because its properties, including biocompatibility, hydrolytically degradable, low
toxicity, and gelation can be promoted easily by divalent cations, such as Ca2+ [20]. Hydrogen
peroxide is generated in the first step reaction of calcium peroxide; hence, catalase was added to
the culture medium to induce decomposition of residual reactive oxygen species [21-23].
Oxygen generating scaffolds were prepared at five different concentrations of alginate,
for encapsulating calcium peroxide particles. The scaffolds were constructed and placed into a
chamber at hypoxic settings. After scaffolds were exposure to the culture medium, bubbles were
observed on the surface. Figure 3.7 shows the tendency of the oxygen generating in function of
the concentration of alginate hydrogel. Scaffolds with the highest relative concentration of
alginate showed a prolonged oxygen generating. Alginate degradation was observed when
oxygen measurements reached background levels, which it can be attributed to the increasing of
the pH inside the scaffold, induced by the presence of H2O2 [24].
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Figure 3.7. Oxygen generating measurements from scaffolds under hypoxic conditions; relative
concentrations 8:1, 10:1, 12:1, 14:1 and 16:1
The results indicate that incorporating calcium peroxide into alginate scaffolds can
provide oxygen concentrations above 0.05 mol/m3 for a period of 120 hours. Scaffold containing
16:1 (alginate: CaO2) had a stable oxygen supply similar to PLGA scaffolds evaluated in
previous studies [5]. Table 3.1 shows the reaction efficiency of calcium peroxide encapsulated
and non-encapsulated when is in direct contact with culture medium. The CaO2 reaction data was
obtained in previous chapter. CaO2 exhausted in 30 hours when exposed to culture medium,
while CaO2 encapsulated with alginate hydrogel exhausted in 140 hours. The area under the
curve was estimated by numerical integration as described below:

∑

Eq. 3.1

The percentage yield was estimated by dividing the area under the curve (mol/m3) over
the total amount of theoretical O2 that can be generated by the CaO2/Medium correlation of
0.2%. The data is showed in Appendix 1. The oxygen generated by the scaffolds was compared
48

to the results obtained in previous chapter, where calcium peroxide particles were exposure
directly to medium. The results indicate a higher percent yield in the oxygen generating scaffolds
(16:1) than non-encapsulated CaO2. These were attributed to errors measurements and an
overestimation, because the O2 diffusion into the atmosphere was not accounted for.

Table 3.1. Percentage yield of Scaffold ratio 16:1 (alginate-CaO2), and CaO2/medium correlation
of 0.2%
2

Group

Total O2 generated

Scaffold ratio 16:1

6.087 mol/m3

78.96%

3.640 mol/m3

47.2%

100

2

(alginate-CaO2)
CaO2/Medium 0.2%

This study indicates that oxygen generating scaffolds fashioned with calcium peroxide
microparticles encapsulated with alginate hydrogels can increase oxygen concentrations to
suitable cellular conditions when the scaffold is surrounding of a hypoxic environment. This
scaffold maintains oxygen levels appropriate for fibroblast cells [9] for a period of 120 hours.
Oxygen measurements were performed to the culture media; hence, high oxygen concentration
may be present inside the scaffold. These results suggested evaluating this oxygen generating
scaffold with fibroblast cells under a hypoxic environment, and asses cell viability for a period of
120 hours.
3.4

CONCLUSIONS
Oxygen generating scaffolds capable of provide suitable oxygen concentrations were

constructed. Calcium peroxide microparticles were used as oxygen generating compounds. These
microparticles were dispensed by the inkjet printing technology, where position and mass were
controlled. Calcium peroxide microparticles provide continuous oxygen generating for a long
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period when encapsulated with alginate hydrogels. This study shown that oxygen generating by
alginate/CaO2 scaffolds are able to supply oxygen concentration suitable for cell culturing. This
scaffold may represent a significant advance for tissue engineering where oxygen supply limited
the creation of large engineered implants.
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Chapter 4
Oxygen Generating Scaffolds to Enhance Cell Viability under Hypoxic
Environment

4.1

INTRODUCTION
Creation of large engineered tissues is still a challenge for tissue engineering because the

slow rates of angiogenesis [1]. To overcome this limitation, different methods are proposed, all
aiming at providing a suitable oxygen supply to engineered tissues. These include growth
factors, synthetic oxygen carries, and oxygen generating biomaterials [2-4]. Oxygenated
scaffolds were created in previous studies mixing hydrophobic materials with oxygen generating
compounds for improving cell environment [4, 5]. However studies with hydrophilic materials
and hydrogels have not been performed yet. In addition, improvements of oxygen generating
scaffolds that control the oxygen generated with better spatial resolution are warranted, because
the existing materials merely generate oxygen gradients which can induce hypoxia affecting the
ATP generation from cells, or hyperoxia that can damage cell membrane [6]. Inkjet printing may
be in particular advantage, dispensing biomaterials and/or microparticles in a controlled pattern
[7], this technology can be applied to deposit biomaterials with micro-gram precision. Calcium
peroxide (CaO2) when is in contact with water decomposes in hydrogen peroxide. Oxygen is
generated in a second reaction [8], which requires a catalyst to accelerate the decomposition and
prevent cell damage [9, 10, 11]. Naturally derived hydrogels are used in tissue engineering as
scaffolds and drug delivery vehicles. Alginate hydrogel, in particular, is a naturally derived
hydrophilic polymer, which is biocompatible, and gelation is achieved with divalent cations such
as Ca++ under mild conditions [12]. Alginate hydrogels are used in cardiac tissue engineering
application amongst others [13]. In this study oxygen generating scaffolds were constructed to
improve cell viability under hypoxic conditions. CaO2 microparticles were printed in a controlled
pattern and density, encapsulated with alginate hydrogel to provide a continuous oxygen supply.
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Fibroblast L-Cells were selected as a cell model, and previous studies demonstrated that
mitochondrial activity of this cell line is optimal in oxygen levels of 0.05 mol/m3 to 0.13
mol/m3[15], which makes this cell line ideal to study the effect of hypoxia and oxygen
generating from tissue engineering scaffolds.
4.2

MATERIALS AND METHODS

4.2.1 MTS assay under Normoxic and Hypoxic conditions
Fibroblast L-cells were donated by Dr. Armando Varela coordinator of I Lab/Research at
the University of Texas at El Paso. L-cells were cultured for 3 days in standards conditions (0.18
mol/m3 O2, 37 ºC, 5% CO2) in Dulbecco’s modified Eagle’s medium (DMEM) augmented with
10% Fetal Bovine Serum (FBS), and 5% of penicillin, all obtained from Gibco (San Diego, CA).
Cultured cells were trypsinized and divided in two equal batches. One batch was placed in a lab
culture hood, the other in a hypoxic chamber. Five different cell concentrations were prepared
for each batch: 1x105 cells/mL, 2x105 cells/mL, 3x105 cells/mL, and 4x105 cells/mL.
Scaffolds were formed by physically cross-linking of alginate chains (Acros Organics,
NJ) dissolved in sterilized phosphate buffered saline (PBS) (2% w/v) with calcium chloride
(Acros Organics, NJ) (0.25M). The gels were sterilized by washing thoroughly with ethanol and
placing under UV light for 30 minutes. Scaffolds were washed with sterile PBS prior to be
transferred to well-plates. CellTiter 96® aqueous one solution reagent (MTS) obtained from
Promega (Madison, WI) was used to evaluate the mitochondrial activity from L-cells under
hypoxic and normoxic environments. L-cells were seeded onto alginate scaffolds at different
densities: 1x105cells/mL, 2x105 cells/mL, 3x105 cells/mL, and 4x105 cells/mL. MTS assays were
performed 1 hour after cells seeding. Subsequently, 20µl of MTS was added per 100 µl of media
in each well. Plates were incubated for 2 hours at 37 ºC, the DMEM/MTS solutions were
transferred into new wells to avoid hydrogel interference, and the absorbance was read at 490 nm
using an automated plate reader (BioTek, Winooski, VT). As various conditions (media, serum,
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pH, light exposure, presence of other chemicals, light exposure) can affect the background
absorbance, ‘no cell’ controls were included for background adjustment.
4.2.2

Oxygen generating scaffolds construction
Oxygen generating scaffolds were fabricated by encapsulating oxygen generating

particles in alginate. 10 mg of calcium peroxide microparticles obtained from Sigma-Aldrich (St.
Louis, MO) were suspended in 200-proof ethanol, filtered, pipetted into a black inkjet cartridge
(HP29) and printed layer-by-layer with a modified inkjet printer HP692C, forming a 25 dots
pattern, which was designed using Microsoft PowerPoint. The black cartridge was emptied and
rinsed thoroughly with ethanol prior to introduce the CaO2 suspension. The printed patterns were
encapsulated with a 2% alginate (Acros Organics, NJ) at a solution in PBS. Then, 0.25M calcium
chloride solution in DI water (Acros Organics, NJ) was sprayed onto the alginate to obtain a
scaffold. Alginate to calcium peroxide ratio was 16:1. Control scaffolds without CaO2 were
fabricated with only alginate. Oxygen generating scaffolds, and control scaffolds were washed
with ethanol and exposed to UV light radiation for 30 minutes. Scaffolds were washed with
sterilized PBS prior transferred to well-plates.
4.2.3

Oxygen Generating Scaffolds Evaluation
L-cells were seeded onto each scaffold. 100 U/ml of catalase (Sigma-Aldrich, St. Louis,

MO) was added to the media to react with hydrogen peroxide byproducts. Scaffolds cultured at
normoxic (0.18 mol/m3 O2, 5% CO2, 37 ºC) were positive control. The remaining scaffolds were
cultured at hypoxic conditions (0.01 mol/m3 O2, 5% CO2, 37 ºC) using a specially designed
culture system (BioSpherix, Lacona, NY), where negative control scaffolds contained no CaO2;
the other scaffolds containing the 16:1 ratio of alginate to CaO2 were labeled as oxygen
generating (OG) scaffolds. The mitochondrial activity was evaluated every day for each control
and the OG scaffolds by the MTS assay.
Cell viability of the L-cells was evaluated after 120 hours with LIVE/DEAD assay
(LIVE/DEAD viability/Cytotoxicity kit) bought from Invitrogen. Culture media was removed for
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each scaffold group and the cells washed with Dulbecco’s phosphate saline solution (PBS)
(Sigma). A solution was prepared containing a ratio of 4µL of Ethidium homodimer-1 (EthD-1) 1µL of calcein per 2 mL of PBS. The LIVE/DEAD assay solution was poured onto each scaffold
until the liquid covered 1 mm level above the scaffold surface. The samples were incubated at
normoxic environment (0.18 mol/m3 O2, 5% CO2, 37 ºC) for 30 minutes. The LIVE/DEAD assay
solution was removed, and 10% buffer formalin solution was added to fix the cells to the
scaffolds. After 30 minutes with 10% buffer formalin solution in the dark and room temperature,
the scaffolds were transferred to a petri-dish with the top surface of the scaffold inverted in the
base of the plate, for observing the cells using a confocal microscope Nikon-D Eclipse (Nikon
Instruments, Melville, NY).

4.3

RESULTS
The results of the mitochondrial activity evaluation of the L-cells seeded onto alginate

hydrogel scaffolds are represented in the figure 4.1, which show the absorbance values as
function of the cell density per mL under normoxic and hypoxic environments. These results
show that oxygen concentration affects the absorbance values obtaining different results at
normoxia in comparison with hypoxia using same cell density. The absorbance values at
normoxia were approximately 1.75 times higher than cells evaluated at hypoxia. The trendline
equations obtained to predict cell density with absorbance values at normoxia and hypoxia
conditions are showed below:

Eq. 4.1

Eq. 4.2
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Figure 4.1. Absorbance values with different cells density at normoxic (0.18 mol) and hypoxic
(0.01 mol) conditions. Cells were seeded onto alginate-hydrogel scaffolds.
Absorbance values were obtained by MTS assay. Trendline equations allow
cell/absorbance calculation.
The figure 4.3 shows the alginate-hydrogel scaffold surface, where porosity can be seen
that was generated by the spraying calcium chloride solution. In the figure 4.2 plots of the L-cells
mitochondrial activity that was evaluated onto the oxygen generating (OG) scaffolds and positive
(non-CaO2, normoxia) and negative controls (non-CaO2, hypoxia) are shown. Figure 4.4 shows
the absorbance values converted to number of cells per mL using the equations 4.1 and 4.2 for
normoxia and hypoxia environments respectively. The cell numbers of the OG Scaffolds were
statistical different with respect to negative control (P < 0.05). The cell number decreased with
time in all the groups because the low protein adsorption onto the alginate-hydrogel. Figure 4.5
shows the normalized cell number versus time, where the cell number in the negative control
scaffold (Non-CaO2, hypoxia) decreases 79% after 120 hours of culturing. The positive control
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scaffold (non-CaO2, normoxia), and OG scaffold had 68% and 63% of cells remaining after 120
hours of culturing.
The cell viability at 120 hours is shown in figures from 4.5 to 4.7. These images
correlates well with the results obtained from the MTS assay. Where in the positive control
incubated at normoxic conditions showed the highest cell density attached to the surface of the
scaffolds; the oxygen generating scaffold showed less cell density, and the negative control
showed the least cells attached to the scaffold. The figure 4.6 also shows that the cells primarily
grew in the porous areas that were created by the spraying.

L‐Cell Mitochondrial activity onto alginate
Scaffolds
0.6

Absorbance

0.5
0.4
Control (+)

0.3

Control (‐)
0.2

OG Scaffold

0.1
0
0
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80

100

120

140

Time ‐ Hours

Figure 4.2.

L-cells mitochondrial activity onto alginate scaffolds. Oxygenized scaffolds (OG)
had a higher absorbance in comparison with negative control at hypoxic conditions
of 0.01 mol/m3. (n=3) P < 0.05 between OG Scaffold and Control (-). P<0.05
between OG Scaffold and Control (+).
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Figure 4.3. Alginate-hydrogel Scaffold Surface
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Control (‐)

OG Scaffold

L-cells mitochondrial activity of cells grown on alginate scaffolds. Oxygenized
scaffolds (OG) Control (-) Control (+) are shown.
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Figure 4.5. Fibroblast cells number over time. Oxygenized scaffolds (OG), control (-), and
control (+) are shown.
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Figure 4.6. L-cells cultured on positive control (+) scaffold. Live/dead assay at 125 hours
incubated at normoxic conditions (0.18 mol/m3, 5% CO2, 37 ºC).
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Figure 4.7.

L-Cells cultured onto negative control (-) scaffold. Live/Dead Assay at 120 hours
incubated under hypoxic conditions (0.01 mol/m3, 5% CO2, 37 ºC).
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Figure 4.8. L-cells cultured onto oxygenized scaffolds (OG). Live/Dead Assay at 120 hours of
incubation at hypoxic conditions (0.01 mol/m3, 5% CO2, 37 ºC)

63

4.4

DISCUSSION
Oxygen supply to cells is a critical factor to consider for engineering large tissues.

Because of oxygen diffuses between 100 to 200 µm from blood vessels, only thin tissues are
engineered to date [15, 16]. Different strategies are proposed to stimulate vascularization postimplantation in thick tissues, such as angiogenic growth factors (VEFG) [17], and synthetic
oxygen carriers (perflurocarbons) [18]. However, angiogenic response occurs at a low rate of 42
µm per hour [19]. Hence, the size of engineered tissues constraint is due to necrosis occurs when
is exceeded diffusion limits [20].
In the present study, oxygen generating scaffolds were fabricated by printing calcium
peroxide microparticles (< 40 µm) using the inkjet printing technology [21, 22], encapsulating
them with alginate hydrogels for providing suitable oxygen supply to cells exposed at hypoxic
conditions. Calcium peroxide decomposes via hydration in H2O2, and the oxygen is generated in
a second step reaction [8]. Catalase was added to the culture medium to ensure decomposition of
residual reactive oxygen species [9, 10, 11], avoiding detrimental effect to cells. The role of the
alginate-hydrogel was to decrease the timing reaction of CaO2 and providing a long-term oxygen
supply to cells. Scaffolds fabricated with 16:1 alginate to CaO2 were evaluated under hypoxic
incubation for their ability to steadily supply oxygen to cells over time [6, 24]. The results on
chapter 3 showed that these oxygen generating scaffolds maintain steady oxygen levels of 0.06
mol/m3, which is suitable for fibroblast cell culturing [14]. One concern of using calcium
peroxide as oxygen generating compound is the presence of hydroxide ions that can change the
pH in culture medium. Nevertheless, the pH levels stayed between 6.9 and 7.3 in the culture
media over the 120 hours of experiment. Further studies are required to evaluate the pH inside
the scaffold.
Mitochondrial activity of fibroblast cells seeded onto scaffolds was evaluated for a period
of 120 hours by using MTS assay. The absorbance values obtained from MTS assay were
converted to number of cells per mL by using the equations 4.1 and 4.2 obtained from
normalizing the absorbance values at normoxic and hypoxic environments. Cell proliferation was
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not observed on the scaffolds, because the poor protein absorption onto alginate hydrogels [25].
Alginate hydrogels were modified in previous studies with carbohydrate specific binding
proteins, such as lectins to improve properties of cell adhesion and proliferation [26]. Future
work will be focusing on modifying alginate to induce cell proliferation [27]. Positive control
scaffold and OG scaffold showed higher normalized cell number of 68% and 60% respectively
than negative control scaffold with 21% after 120 hours of incubation; most likely due to the lack
of oxygen. The metabolic rate in OG scaffolds was higher than negative control scaffolds after
120 hours of hypoxic incubation because the oxygen supply of scaffolds. Cell viability among
positive control scaffolds and OG scaffolds was also higher than negative controls in live/dead
assays. However, cells grown on positive control scaffolds showed different morphology, they
had a larger shape and more intensive fluorescence, indicating higher metabolism than other
scaffolds. This suggests that these oxygen-generating scaffolds, while creating a continuous
oxygen supply and improving cell viability under hypoxic incubation, are still far from
recapitulating the normoxic environment needed for normal cell proliferation and differentiation.
However, the OG scaffolds did improve cell viability, and this may be key for building large
constructs of engineered tissues. One hypothesis would be that if one can maintain viability for
an extended time, neovascularization will slowly restore normoxic conditions in implanted
tissues. Vascularization into tissue scaffolds occur approximately 42 µm per hour [28], therefore
alginate-hydrogel scaffolds that maintain cell viability for 120 hours would allow implanting a 5
mm thick of tissue, which would be an improvement of at least a factor of 5 over current
technology.
Hydrophilic oxygen generating scaffolds may be further tuned by modifying their
chemical properties [29] or incorporating others naturally polymers, such as chitosan and
collagen [30, 31, 32], for improving cell attachment and proliferation. Future work will explore
in vivo responses to these scaffolds.
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4.5

CONCLUSIONS
The present study shows the effect of the oxygen generating scaffolds for enhancing cell

viability under hypoxic environment in vitro. Calcium peroxide particles dispensed by inkjet
printers were used as oxygen generating compound, which provided extended oxygen supply
when encapsulated with alginate hydrogels. These scaffolds released oxygen into the culturing
media improving viability under hypoxia. The use of these biomaterials to create scaffolds may
maintain viability for a large period of time, and potentially allowing better vascularization postimplantation. These scaffolds provide an advance to overcome current challenges in tissue
engineering, where implantation of large engineered tissues is limited by the oxygen diffusion.
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Chapter 5
Conclusions
This study was focused on fabricating oxygen generating scaffolds with applications in
tissue engineering by using the inkjet printing technology, calcium peroxide microparticles, and
alginate-hydrogel. The principal objective was to create scaffolds able to maintain cell viability
by supplying oxygen when exposed to a hypoxic environment.
A modified off-the-shelf inkjet printer allowed printing calcium peroxide microparticles
(< 40 µm) in a layer-by-layer fashion, controlling the amount and the pattern dispensed. Oxygen
concentration generated by the hydrolytic decomposition of calcium peroxide was evaluated
under hypoxic environments.
Three different concentrations of hydrophilic hydrogels composed of alginate and
calcium chloride, were used to encapsulate the oxygen generating compounds, and delay the
oxygen release. Hydrogels containing 16:1 alginate to CaO2 allowed a continuous oxygen supply
above 0.05 mol/m3 for up to 120 hours. After 120 hours, degradation of the hydrogel occurred
most likely because the continuous generation of hydrogen peroxide.
Fibroblast cells (L-cell) were seeded onto oxygen generating scaffolds, positive and
negative controls scaffolds. Oxygen generating scaffolds and negative control scaffolds were
incubated under hypoxic conditions, while positive scaffolds were cultured at standard
conditions. Mitochondrial activity was evaluated by the MTS assay, where absorbance values
were correlated directly to number of cells; they did not proliferate onto the scaffolds because of
alginate hydrogel properties, but remained viable in the positive control with 68% after 120
hours. Viability was also assessed in the other groups after 120 hours of culturing. The viability
of cells grown on the oxygen generating scaffolds was 60%, while cells frown on the negative
control scaffolds were 21%. Live/dead assay corroborated these results; the highest cell density
was observed on the surface of the oxygen-generating scaffolds in comparison with negative
control scaffold.
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The results suggest that these oxygen-generating scaffolds are able to create a continuous
oxygen supply and improving cell viability under hypoxic incubation, nevertheless, are still far
from recapitulating the normoxic environment needed for normal cell proliferation and
differentiation. However, the scaffolds did improve cell viability, and this may be key for
building large constructs of engineered tissues. One hypothesis would be that if scaffolds can
maintain viability for an extended time, neovascularization will slowly restore normoxic
conditions in implanted tissues. Vascularization into tissue scaffolds occurs approximately 42
µm per hour; therefore, alginate-hydrogel scaffolds that maintain cell viability for 120 hours
would allow to implant a 5 mm thick of tissue, which would be an improvement of at least a
factor of 5 over current technology.
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Appendix 1
Calculation of area under the curve by numerical integration
The total oxygen generated was obtained calculating the area under the curve by
numerical integration (trapezoidal rule) as described below:

2
Where:
(a – b) is the time spacing, and [f(xk), f(xk+1)] are the sensor measurements at time a and b
respectively.
APPENDIX 1.1
Data used for calculation of oxygen generated by CaO2/Medium proportion: 0.02%,
0.10% and 0.20% is showed below. The background oxygen level was removed to obtain only
oxygen generated by calcium peroxide.

0.02% of CaO2/medium

0.2% of CaO2/medium

0.1% of CaO2/medium

Time
(hours)

Oxygen
measurements
(mol/m3)

Numerical
Integration
(mol/m3)

Time
(Hours)

Oxygen
measurement
(mol/m3)

Numerical
Integration
(mol/m3)

Time
(Hours)

Oxygen
measurements
(mol/m3)

Numerical
Integration
(mol/m3)

0.2500

0.0822

0.0103

0.2500

0.1888

0.0236

0.2500

0.4306

0.0538

0.3500

0.0741

0.0181

0.3417

0.1850

0.0407

0.4167

0.3506

0.1189

0.4333

0.0831

0.0246

0.4167

0.1769

0.0543

0.5833

0.3041

0.1735

0.5000

0.0938

0.0305

0.5000

0.1866

0.0694

0.7500

0.2869

0.2227

0.6667

0.0816

0.0451

0.6667

0.1553

0.0979

1.0000

0.2431

0.2890

0.8333

0.0716

0.0579

0.8333

0.1478

0.1232

1.6667

0.2213

0.4438

1.0000

0.0731

0.0700

1.0000

0.1447

0.1476

2.0000

0.2003

0.5141

1.5000

0.0553

0.1021

1.3333

0.1603

0.1984

2.5000

0.2219

0.6196

2.0000

0.0563

0.1300

2.0000

0.1194

0.2916

3.0000

0.2238

0.7310

2.5000

0.0378

0.1535

2.5000

0.1209

0.3517

3.5000

0.1763

0.8310

3.0000

0.0447

0.1741

3.0000

0.1288

0.4141

4.0000

0.1703

0.9177

3.5000

0.0388

0.1950

3.5000

0.1275

0.4782

5.0000

0.1794

1.0925

4.0000

0.0263

0.2112

4.0000

0.1172

0.5394

6.0000

0.1606

1.2625

4.5000

0.0216

0.2232

4.5000

0.1181

0.5982

7.0000

0.1588

1.4222
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5.0000

0.0191

0.2333

5.0000

0.1059

0.6542

14.0000

0.0953

2.3115

5.6667

0.0144

0.2445

5.6667

0.1203

0.7296

15.0000

0.1188

2.4185

6.1667

0.0119

0.2510

6.1667

0.1125

0.7879

16.0000

0.1853

2.5705

6.8333

0.0100

0.2583

6.8333

0.0941

0.8567

17.0000

0.2144

2.7704

7.3333

0.0097

0.2633

7.3333

0.0947

0.9039

18.0000

0.1925

2.9738

8.5000

0.0081

0.2736

8.5000

0.0975

1.0160

19.0000

0.1369

3.1385

14.0000

0.0588

1.4457

20.0000

0.1088

3.2614

15.0000

0.0713

1.5107

21.0000

0.0619

3.3467

16.0000

0.0822

1.5874

22.0000

0.0500

3.4026

17.0000

0.0959

1.6765

23.0000

0.0531

3.4542

18.0000

0.0528

1.7509

24.0000

0.0466

3.5040

19.0000

0.0616

1.8081

25.0000

0.0375

3.5461

20.0000

0.0622

1.8700

26.0000

0.0281

3.5789

21.0000

0.0547

1.9284

27.0000

0.0203

3.6031

22.0000

0.0281

1.9698

28.0000

0.0131

3.6198

23.0000

0.0197

1.9937

29.0000

0.0097

3.6312

24.0000

0.0113

2.0092

30.0000

0.0084

3.6403

25.0000

0.0066

2.0181

APPENDIX 1.2
Data used for calculation of oxygen generated by scaffolds with relative concentration of
16:1 alginate CaO2 is showed below. The background oxygen level was removed to obtain only
oxygen generated by calcium peroxide.

Scaffold relative concentration 16:1
Time
(Hours)

Oxygen
measurement
mol/m3

Numerical
Integration
mol/m3

0
1
23
46
72
96
120
144

0
0.0469
0.0516
0.0491
0.0472
0.0431
0.0397
0.0016

0
0.0234
1.1063
2.2635
3.5149
4.5987
5.5925
6.0875
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Appendix 2
MTS assay from Promega
DESCRIPTION
The CellTiter 96® AQueous One Solution Cell Proliferation Assay (MTS assay) is a
colorimetric method for determining the number of viable cells in proliferation or cytotoxicity
assays. The MTS assay contains a novel tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt] and an electron
coupling reagent (phenazine ethosulfate; PES).
The MTS tetrazolium compound is bioreduced by cells into a colored formazan product
that is soluble in tissue culture medium. This conversion is presumably accomplished by
NADPH or NADH produced by dehydrogenase enzymes in metabolically active cells. Assays
are performed by adding a small amount of the MTS directly to culture wells, incubating for 1–4
hours and then recording the absorbance at 490nm. The quantity of formazan product as
measured by absorbance at 490nm is directly proportional to the number of living cells in
culture.
GENERAL PROTOCOL
1. Thaw the CellTiter 96® AQueous One Solution Reagent.
2. Pipet 20µl of CellTiter 96® AQueous One Solution Reagent per each 100µl of culture
medium into each culture well.
3. Incubate the plate at 37°C for 1–4 hours in a humidified, 5% CO2 atmosphere.
4. Record the absorbance at 490nm
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